Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first line therapy.

by Uwe ePelzer, Andreas eHilbig, Jens eStieler, Marianne eSinn, Marcus eBahra, Bernd eDörken, Hanno eRiess
Published 2013-06-01

Blood group determinates incidence for pancreatic cancer in Germany.

by Uwe ePelzer, Fritz eKlein, Marcus eBahra, Marianne eSinn, Bernd eDörken, Peter eNeuhaus, Oliver eMeyer, Hanno eRiess
Published 2013-05-01